671 related articles for article (PubMed ID: 17652277)
1. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.
Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P
J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of homing receptors and vascular addressins in tonsils and draining lymph nodes: Effect of Brucella infection in sheep.
Suraud V; Olivier M; Bodier CC; Guilloteau LA
Vet Immunol Immunopathol; 2007 Feb; 115(3-4):239-50. PubMed ID: 17161868
[TBL] [Abstract][Full Text] [Related]
3. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1.
Sikorski EE; Hallmann R; Berg EL; Butcher EC
J Immunol; 1993 Nov; 151(10):5239-50. PubMed ID: 7693807
[TBL] [Abstract][Full Text] [Related]
4. Induction of vascular addressins and adhesion molecules in the pancreas of IFN-gamma transgenic mice.
Lee MS; Sarvetnick N
J Immunol; 1994 May; 152(9):4597-603. PubMed ID: 7512601
[TBL] [Abstract][Full Text] [Related]
5. Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site.
Csencsits KL; Jutila MA; Pascual DW
J Immunol; 1999 Aug; 163(3):1382-9. PubMed ID: 10415038
[TBL] [Abstract][Full Text] [Related]
6. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation.
Rott LS; Briskin MJ; Andrew DP; Berg EL; Butcher EC
J Immunol; 1996 May; 156(10):3727-36. PubMed ID: 8621908
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells.
Picarella D; Hurlbut P; Rottman J; Shi X; Butcher E; Ringler DJ
J Immunol; 1997 Mar; 158(5):2099-106. PubMed ID: 9036954
[TBL] [Abstract][Full Text] [Related]
9. Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium.
Hänninen A; Taylor C; Streeter PR; Stark LS; Sarte JM; Shizuru JA; Simell O; Michie SA
J Clin Invest; 1993 Nov; 92(5):2509-15. PubMed ID: 7693764
[TBL] [Abstract][Full Text] [Related]
10. Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissues.
Csencsits KL; Jutila MA; Pascual DW
Eur J Immunol; 2002 Nov; 32(11):3029-39. PubMed ID: 12385022
[TBL] [Abstract][Full Text] [Related]
11. Expression of L-selectin ligands by transformed endothelial cells enhances T cell-mediated rejection.
Biancone L; Stamenkovic I; Cantaluppi V; Boccellino M; De Martino A; Bussolino F; Camussi G
J Immunol; 1999 May; 162(9):5263-9. PubMed ID: 10228001
[TBL] [Abstract][Full Text] [Related]
12. The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: implications for xenotransplantation.
Robinson LA; Tu L; Steeber DA; Preis O; Platt JL; Tedder TF
J Immunol; 1998 Dec; 161(12):6931-8. PubMed ID: 9862727
[TBL] [Abstract][Full Text] [Related]
13. Spatial heterogeneity of TNF-alpha-induced T cell migration to colonic mucosa is mediated by MAdCAM-1 and VCAM-1.
Watanabe C; Miura S; Hokari R; Teramoto K; Ogino T; Komoto S; Hara Y; Koseki S; Tsuzuki Y; Nagata H; Granger DN; Ishii H
Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1379-87. PubMed ID: 12388196
[TBL] [Abstract][Full Text] [Related]
14. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
[TBL] [Abstract][Full Text] [Related]
15. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
16. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
[TBL] [Abstract][Full Text] [Related]
17. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
Kao JK; Hsue YT; Lin CY
J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
[TBL] [Abstract][Full Text] [Related]
18. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
19. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O
J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177
[TBL] [Abstract][Full Text] [Related]
20. Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.
Delfortrie S; Pinte S; Mattot V; Samson C; Villain G; Caetano B; Lauridant-Philippin G; Baranzelli MC; Bonneterre J; Trottein F; Faveeuw C; Soncin F
Cancer Res; 2011 Dec; 71(23):7176-86. PubMed ID: 22037871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
